These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 13993111)

  • 1. Effects of patent abolition on the drug industry.
    SMITH A
    Appl Ther; 1963 May; 5():433-7. PubMed ID: 13993111
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of drug patent abolition on an international pharmaceutical company.
    DAILY RF
    Appl Ther; 1963 May; 5():445-7. PubMed ID: 14024668
    [No Abstract]   [Full Text] [Related]  

  • 3. Patent alert.
    IDrugs; 2003 Aug; 6(8):811-9. PubMed ID: 12971396
    [No Abstract]   [Full Text] [Related]  

  • 4. Patent alert.
    Noprman P; Whelan C; Press N
    IDrugs; 2003 Dec; 6(12):1198-1204. PubMed ID: 14712832
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of drug patent abolition on a Canadian pharmaceutical company.
    LOZINSKI E
    Appl Ther; 1963 May; 5():441-2. PubMed ID: 13931335
    [No Abstract]   [Full Text] [Related]  

  • 6. Patent news.
    Steele P; Sparrowhawk M
    IDrugs; 2005 Jun; 8(6):508-10. PubMed ID: 15966134
    [No Abstract]   [Full Text] [Related]  

  • 7. Patent news.
    Steele P; Sparrowhawk M
    IDrugs; 2003 Jan; 6(1):79-81. PubMed ID: 12838979
    [No Abstract]   [Full Text] [Related]  

  • 8. Enforcing pharmaceutical and biotech patent rights in China.
    Zhang YP; Deng MM
    Nat Biotechnol; 2008 Nov; 26(11):1235-40. PubMed ID: 18997760
    [No Abstract]   [Full Text] [Related]  

  • 9. The use of generic or patent medicines in the Netherlands.
    Gebhardt DO
    J Med Ethics; 2005 Jul; 31(7):409. PubMed ID: 15994361
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug patent plan gets mixed reviews.
    Butler D
    Nature; 2009 Feb; 457(7233):1064. PubMed ID: 19256077
    [No Abstract]   [Full Text] [Related]  

  • 11. A day late and a few million dollars short.
    Goldenson D
    Nat Biotechnol; 2009 Jun; 27(6):538-41. PubMed ID: 19513055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinase patent space visualization using chemical replacements.
    Southall NT; Ajay
    J Med Chem; 2006 Mar; 49(6):2103-9. PubMed ID: 16539399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pills, patents, and power: state creation of gray markets as a limit on patent rights.
    Ghosh S
    Fla J Int Law; 2002; 14(2):217-60. PubMed ID: 16526138
    [No Abstract]   [Full Text] [Related]  

  • 14. Should the patent system for new medicines be abolished?
    DiMasi JA; Grabowski HG
    Clin Pharmacol Ther; 2007 Nov; 82(5):488-90. PubMed ID: 17952100
    [No Abstract]   [Full Text] [Related]  

  • 15. A consideration of the patentability of enantiomers in the pharmaceutical industry in the United States.
    Miller CP; Ullrich JW
    Chirality; 2008 Jun; 20(6):762-70. PubMed ID: 18200591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The status of a nonpatented drug of which the basic molecule in patented].
    Petranker L; Stenger J
    Ann Pharm Fr; 1975 Nov; 33(11):619-25. PubMed ID: 1231608
    [No Abstract]   [Full Text] [Related]  

  • 17. [European patent].
    Saviotti G
    Farmaco Prat; 1974 Jan; 29(1):18-20. PubMed ID: 4455518
    [No Abstract]   [Full Text] [Related]  

  • 18. Biotech patents-business as usual?
    Lawrence S
    Nat Biotechnol; 2008 Dec; 26(12):1326. PubMed ID: 19060861
    [No Abstract]   [Full Text] [Related]  

  • 19. Drug research. WHO panel weighs radical ideas.
    Enserink M
    Science; 2006 Dec; 314(5804):1373. PubMed ID: 17138875
    [No Abstract]   [Full Text] [Related]  

  • 20. Are drug proprietary names necessary?
    D'Arcy PF; Hadden DR
    Adverse Drug React Toxicol Rev; 2000 Jun; 19(2):117-21. PubMed ID: 10967746
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.